Name | Last modified | Size | Description | |
---|---|---|---|---|
Parent Directory | - | |||
SOP-CoPCT-KH.pdf | 2021-02-17 08:31 | 40M | ||
Book-CoPCT-Kh.pdf | 2021-02-22 15:33 | 40M | ||
SOP-CoPCT-EN.pdf | 2021-02-17 08:44 | 38M | ||
Book-CoPCT-English.pdf | 2021-02-22 15:30 | 38M | ||
Guidance-to-enhance-..> | 2021-02-19 17:20 | 36M | ||
Guidance-to-the-Oper..> | 2021-02-19 17:12 | 33M | ||
SOP-CQI-KH.pdf | 2021-02-17 07:56 | 24M | ||
Guidance-to-enhance-..> | 2021-02-19 17:18 | 24M | ||
Guidance-to-the-Oper..> | 2021-02-19 17:11 | 23M | ||
OI_ART_User_Manual.pdf | 2021-02-20 16:44 | 20M | ||
VCCT_User_Manual.pdf | 2021-02-20 16:47 | 20M | ||
STD_User_Manual.pdf | 2021-02-20 16:51 | 20M | ||
SOP-CQI-EN.pdf | 2021-02-17 08:01 | 15M | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 15M | ||
Standard-Protocol-Ba..> | 2021-02-17 03:47 | 10M | ||
CQI_dashboard_usergu..> | 2021-02-20 16:54 | 9.9M | ||
Guidline-screening-o..> | 2021-02-16 06:50 | 9.7M | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 8.1M | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 7.8M | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 7.8M | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 7.7M | ||
National-Guidelines-..> | 2021-02-19 17:30 | 7.3M | ||
SOP-Book_khm_V4.pdf | 2021-02-23 15:11 | 7.1M | ||
slides-sti-kh.pdf | 2021-02-16 15:39 | 7.1M | ||
D4T-Phasing-Out-KH.pdf | 2021-02-17 07:28 | 7.0M | ||
Guidline-screening-o..> | 2021-02-16 06:49 | 6.9M | ||
National_Guideline_S..> | 2021-02-15 09:26 | 6.7M | ||
slides-sti-en.pdf | 2021-02-16 15:46 | 6.6M | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 6.5M | ||
Adult_HIV_Management..> | 2021-02-16 06:39 | 6.5M | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 6.3M | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 6.0M | ||
National-Guidelines-..> | 2021-02-19 17:30 | 5.9M | ||
Standard-Protocol-Ba..> | 2021-02-17 03:54 | 5.8M | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 5.7M | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 5.5M | ||
SOP-Book_EN_V4.pdf | 2021-02-23 15:10 | 5.4M | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 5.4M | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 5.4M | ||
Agreement_NCHADSNBTC..> | 2021-02-16 09:26 | 5.4M | ||
Adult_HIV_Management..> | 2021-02-16 06:38 | 5.3M | ||
sti-q3-2008.pdf | 2021-02-28 08:02 | 5.0M | ||
National-Consolidate..> | 2021-02-19 17:37 | 5.0M | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 4.9M | ||
D4T-Phasing-Out-EN.pdf | 2021-02-17 07:32 | 4.9M | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:14 | 4.7M | ||
linkresponse-q1-2009..> | 2021-02-27 08:36 | 4.7M | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 4.7M | ||
ACM_Book-2013.pdf | 2021-02-20 16:40 | 4.6M | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 4.4M | ||
sti-q4-2008.pdf | 2021-02-28 08:05 | 4.2M | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 3.9M | ||
sti-q2-2008.pdf | 2021-02-28 07:48 | 3.8M | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 3.6M | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:33 | 3.6M | ||
National-Guidelines-..> | 2021-02-21 16:43 | 3.5M | ||
National-Guide-on-ST..> | 2021-02-21 16:40 | 3.2M | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:49 | 3.2M | ||
oi-q3-2008.pdf | 2021-02-28 08:01 | 3.2M | ||
STI-Sentinel-Survey-..> | 2021-02-28 09:17 | 3.2M | ||
NG_on_Management_of_..> | 2021-02-20 16:27 | 3.1M | ||
HSS_2010-Report.pdf | 2021-02-15 15:52 | 3.0M | ||
art-q3-2007.pdf | 2021-02-28 08:12 | 3.0M | ||
oi-q2-2008.pdf | 2021-02-28 07:48 | 3.0M | ||
oi-q3-2007.pdf | 2021-02-28 08:12 | 2.9M | ||
oi-q1-2008.pdf | 2021-02-28 07:43 | 2.9M | ||
art-q3-2008.pdf | 2021-02-28 08:01 | 2.9M | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 2.8M | ||
sti-q3-2009.pdf | 2021-02-27 08:45 | 2.8M | ||
National-Consolidate..> | 2021-02-19 17:37 | 2.8M | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 2.7M | ||
art-q2-2008.pdf | 2021-02-28 07:48 | 2.7M | ||
oi-q4-2007.pdf | 2021-02-28 08:18 | 2.6M | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 2.6M | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 2.6M | ||
art-q1-2008.pdf | 2021-02-28 07:43 | 2.6M | ||
art-q4-2007.pdf | 2021-02-28 08:18 | 2.6M | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:48 | 2.6M | ||
sti-q1-2008.pdf | 2021-02-28 07:43 | 2.6M | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 2.6M | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 2.5M | ||
Female-worker-KH.pdf | 2021-02-23 15:28 | 2.5M | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 2.4M | ||
linkresponse-q3-2009..> | 2021-02-27 08:45 | 2.4M | ||
OI-q1-2006.pdf | 2021-02-28 08:23 | 2.3M | ||
sti-q2-2009.pdf | 2021-02-27 08:41 | 2.2M | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 2.2M | ||
Female-worker-EN.pdf | 2021-02-23 15:28 | 2.2M | ||
guide3.pdf | 2021-02-21 09:33 | 2.2M | ||
tb-q4-2009.pdf | 2021-02-27 09:00 | 2.2M | ||
RACHA-KH.pdf | 2021-02-16 15:22 | 2.1M | ||
National-Guidelines-..> | 2021-02-20 16:59 | 2.0M | ||
Agreement-NCHADS-AHF..> | 2021-02-16 14:28 | 2.0M | ||
ART-q1-2006.pdf | 2021-02-28 08:23 | 1.9M | ||
Agreement-Nchads-Mag..> | 2021-02-15 15:36 | 1.9M | ||
vcct-q4-2008.pdf | 2021-02-28 08:05 | 1.9M | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 1.9M | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:13 | 1.9M | ||
LOA_-NCHADS_KHANA_20..> | 2021-02-16 14:39 | 1.8M | ||
STI-q3-2007.pdf | 2021-02-28 08:13 | 1.8M | ||
vcct-q3-2009.pdf | 2021-02-27 08:45 | 1.7M | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 1.7M | ||
National-Guidelines-..> | 2021-02-20 16:59 | 1.7M | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 1.6M | ||
SOP-for-NCHADS-PBSI-..> | 2021-02-23 15:42 | 1.6M | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 1.6M | ||
guide2.pdf | 2021-02-21 09:36 | 1.6M | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 1.6M | ||
vcct-q3-2008.pdf | 2021-02-28 08:02 | 1.6M | ||
Letter-of-Agreement-..> | 2021-02-16 09:13 | 1.6M | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 1.5M | ||
vcct-q2-2009.pdf | 2021-02-27 08:41 | 1.5M | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 1.5M | ||
core-indicator-kh.pdf | 2021-02-21 16:13 | 1.4M | ||
VCCT-q4-2007.pdf | 2021-02-28 08:18 | 1.4M | ||
Concept-paper-for-sy..> | 2021-02-23 15:25 | 1.4M | ||
psf_ci.pdf | 2021-02-16 14:59 | 1.4M | ||
TasP_NCHADS-Concept-..> | 2021-02-23 15:03 | 1.4M | ||
HBC-q3-2007.pdf | 2021-02-28 08:12 | 1.4M | ||
art-q4-2009.pdf | 2021-02-27 09:00 | 1.4M | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:12 | 1.4M | ||
hbc-q2-2008.pdf | 2021-02-28 07:48 | 1.3M | ||
hbc-q1-2008.pdf | 2021-02-28 07:43 | 1.3M | ||
guideline-CD4350.pdf | 2021-02-21 15:56 | 1.3M | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 1.3M | ||
HBC-q2-2007.pdf | 2021-02-28 08:10 | 1.3M | ||
oi-q1-2009.pdf | 2021-02-27 08:37 | 1.2M | ||
oi-q4-2009.pdf | 2021-02-27 09:00 | 1.2M | ||
LOA-NCHADS-and-CPN.pdf | 2021-02-21 16:21 | 1.2M | ||
STI-q2-2007.pdf | 2021-02-28 08:10 | 1.2M | ||
art-q3-2009.pdf | 2021-02-27 08:44 | 1.2M | ||
oi-q3-2009.pdf | 2021-02-27 08:45 | 1.2M | ||
art-q1-2009.pdf | 2021-02-27 08:36 | 1.2M | ||
art-q4-2008.pdf | 2021-02-28 08:05 | 1.1M | ||
BIACM-Anual-Report-2..> | 2021-02-24 04:41 | 1.1M | ||
oi-q4-2008.pdf | 2021-02-28 08:05 | 1.1M | ||
SOP-KH.pdf | 2021-02-24 07:02 | 1.1M | ||
art-q2-2009.pdf | 2021-02-27 08:41 | 1.1M | ||
oi-q2-2009.pdf | 2021-02-27 08:41 | 1.1M | ||
National-Guide-for-S..> | 2021-02-21 16:37 | 1.1M | ||
linkresponse-q4-2009..> | 2021-02-27 09:00 | 1.0M | ||
hbc-q3-2009.pdf | 2021-02-27 08:44 | 1.0M | ||
sti-q4-2009.pdf | 2021-02-27 09:00 | 1.0M | ||
sti-q1-2009.pdf | 2021-02-27 08:37 | 1.0M | ||
VCCT-q1-2006.pdf | 2021-02-28 08:23 | 1.0M | ||
ART-q2-2006.pdf | 2021-02-28 08:31 | 1.0M | ||
New-Biological-Crite..> | 2021-02-20 16:35 | 1.0M | ||
hbc-q1-2009.pdf | 2021-02-27 08:36 | 973K | ||
RACHA-EN.pdf | 2021-02-16 15:22 | 964K | ||
Lost-to-Follow-up-Le..> | 2021-02-19 17:40 | 962K | ||
SOP-EN.pdf | 2021-02-24 07:02 | 954K | ||
ARV-guideline-2007-K..> | 2021-02-21 16:24 | 942K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 911K | ||
hbc-q2-2009.pdf | 2021-02-27 08:41 | 910K | ||
EWI-2008-2010.pdf | 2021-02-28 15:59 | 886K | ||
hbc-q4-2009.pdf | 2021-02-27 09:00 | 881K | ||
vcct-q4-2009.pdf | 2021-02-27 09:00 | 872K | ||
vcct-q1-2009.pdf | 2021-02-27 08:37 | 832K | ||
linkresponse-q2-2009..> | 2021-02-27 08:41 | 830K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 829K | ||
Concept-Paper-in-Khm..> | 2021-02-23 15:21 | 825K | ||
SOP-TB-and-HIV-ENG.pdf | 2021-02-24 06:46 | 818K | ||
vcct-q1-2008.pdf | 2021-02-28 07:43 | 818K | ||
core-indicator-en.pdf | 2021-02-21 16:12 | 799K | ||
sop-coc-08-en.pdf | 2021-02-23 15:35 | 792K | ||
LOA_NCHADS_CRS.pdf | 2021-02-16 15:10 | 786K | ||
vcct-q2-2008.pdf | 2021-02-28 07:48 | 775K | ||
LOA_NCHADS_worldvisi..> | 2021-02-16 15:04 | 755K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 735K | ||
National-Guideline-f..> | 2021-02-21 16:19 | 724K | ||
VCCT-q2-2006.pdf | 2021-02-28 08:32 | 721K | ||
Concept-Paper-in-Eng..> | 2021-02-23 15:21 | 715K | ||
STI-q4-2007.pdf | 2021-02-28 08:18 | 687K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 672K | ||
SOP-for-Social-Care-..> | 2021-02-24 07:33 | 670K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 664K | ||
tb-q3-2009.pdf | 2021-02-27 08:45 | 654K | ||
Report-B-CoPCT-Annua..> | 2021-02-24 03:31 | 650K | ||
sop-coc-08-kh.pdf | 2021-02-23 15:35 | 641K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 631K | ||
SOP-CDC-KH.pdf | 2021-02-24 07:22 | 627K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 627K | ||
ARV-Guideline-2005-E..> | 2021-02-21 16:28 | 626K | ||
HBC-q4-2007.pdf | 2021-02-28 08:18 | 620K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 619K | ||
SOP-Kh.pdf | 2021-02-24 06:39 | 603K | ||
ARV-guideline-2005-K..> | 2021-02-21 16:28 | 582K | ||
VCCT-q2-2007.pdf | 2021-02-28 08:10 | 577K | ||
SOP-En.pdf | 2021-02-24 06:38 | 562K | ||
VCCT-q3-2006.pdf | 2021-02-28 08:34 | 561K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 558K | ||
positive-prevention-..> | 2021-02-21 09:18 | 557K | ||
OI-q2-2006.pdf | 2021-02-28 08:31 | 554K | ||
ARV-guideline-2007-E..> | 2021-02-21 16:23 | 545K | ||
SOP-CDC-EN.pdf | 2021-02-24 07:22 | 535K | ||
MHS-KH.pdf | 2021-02-16 14:45 | 513K | ||
VCCT-q1-2007.pdf | 2021-02-28 08:08 | 488K | ||
linkresponse-q4-2009..> | 2021-02-27 09:00 | 487K | ||
hbc-q4-2008.pdf | 2021-02-28 08:05 | 453K | ||
positive-prevention-..> | 2021-02-21 09:18 | 449K | ||
SOP-mmm-EN.pdf | 2021-02-23 15:33 | 423K | ||
ART-q1-2006-pdf.jpg | 2021-02-28 08:23 | 417K | ||
SOP-mmm-KH.pdf | 2021-02-23 15:33 | 414K | ||
VCCT-q4-2007-pdf.jpg | 2021-02-28 08:18 | 409K | ||
SOP-for-PBSI-KH.pdf | 2021-02-24 06:41 | 399K | ||
VCCT_User_Manual-pdf..> | 2021-02-20 16:48 | 399K | ||
approval-letter-for-..> | 2021-02-21 09:16 | 395K | ||
report-ewi-2011.pdf | 2021-02-28 15:54 | 386K | ||
OI_ART_User_Manual-p..> | 2021-02-20 16:44 | 382K | ||
SOP-for-HBC-KHM.pdf | 2021-02-24 06:54 | 379K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 378K | ||
Strategic-Plan-2004-..> | 2021-02-21 16:06 | 366K | ||
SOP-for-MMM-ENG.pdf | 2021-02-24 06:48 | 366K | ||
VCCT-q1-2006-pdf.jpg | 2021-02-28 08:23 | 365K | ||
STD_User_Manual-pdf.jpg | 2021-02-20 16:51 | 360K | ||
SOP-for-MMM-KHM.pdf | 2021-02-24 06:48 | 358K | ||
vcct-q1-2008-pdf.jpg | 2021-02-28 07:43 | 349K | ||
linkresponse-q1-2009..> | 2021-02-27 08:36 | 348K | ||
VCCT-q2-2006-pdf.jpg | 2021-02-28 08:32 | 347K | ||
ART-q2-2006-pdf.jpg | 2021-02-28 08:31 | 347K | ||
OI-q1-2006-pdf.jpg | 2021-02-28 08:23 | 346K | ||
MHS-EN.pdf | 2021-02-16 14:45 | 346K | ||
OI-Guideline-Booklet..> | 2021-02-21 16:33 | 336K | ||
STI-q4-2006.pdf | 2021-02-28 08:37 | 334K | ||
vcct-q3-2008-pdf.jpg | 2021-02-28 08:02 | 326K | ||
vcct-q4-2008-pdf.jpg | 2021-02-28 08:05 | 325K | ||
SOP-logistic-EN.pdf | 2021-02-24 07:05 | 322K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 321K | ||
vcct-q1-2009-pdf.jpg | 2021-02-27 08:37 | 320K | ||
oi-q1-2009-pdf.jpg | 2021-02-27 08:37 | 316K | ||
art-q1-2009-pdf.jpg | 2021-02-27 08:36 | 313K | ||
linkresponse-q3-2009..> | 2021-02-27 08:45 | 311K | ||
SOP-ORCUP-KH.pdf | 2021-02-24 07:00 | 309K | ||
Strategic-Plan-2001-..> | 2021-02-21 16:09 | 305K | ||
HBC-q2-2007-pdf.jpg | 2021-02-28 08:10 | 303K | ||
vcct-q2-2008-pdf.jpg | 2021-02-28 07:48 | 301K | ||
CQI_dashboard_usergu..> | 2021-02-20 16:54 | 299K | ||
vcct-q2-2009-pdf.jpg | 2021-02-27 08:41 | 297K | ||
Female-worker-KH-pdf..> | 2021-02-23 15:28 | 295K | ||
HBC-q3-2007-pdf.jpg | 2021-02-28 08:12 | 294K | ||
hbc-q2-2008-pdf.jpg | 2021-02-28 07:48 | 293K | ||
hbc-q1-2008-pdf.jpg | 2021-02-28 07:43 | 293K | ||
Guidance-to-enhance-..> | 2021-02-19 17:20 | 293K | ||
VCCT-q2-2007-pdf.jpg | 2021-02-28 08:10 | 286K | ||
FHI-KH.pdf | 2021-02-16 15:17 | 282K | ||
vcct-q4-2009-pdf.jpg | 2021-02-27 09:00 | 282K | ||
VCCT-q3-2007-pdf.jpg | 2021-02-28 08:13 | 279K | ||
SOP-TB-and-HIV-ENG-p..> | 2021-02-24 06:46 | 279K | ||
SOP-for-PBSI-EN.pdf | 2021-02-24 06:41 | 278K | ||
OI-q2-2006-pdf.jpg | 2021-02-28 08:31 | 277K | ||
National-Guidelines-..> | 2021-02-21 16:43 | 277K | ||
SOP-for-HBC-ENG.pdf | 2021-02-24 06:54 | 276K | ||
Rapid-assessment-kh.pdf | 2021-02-28 16:02 | 276K | ||
HBC-q1-2007-pdf.jpg | 2021-02-28 08:08 | 274K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 273K | ||
sti-q4-2009-pdf.jpg | 2021-02-27 09:00 | 269K | ||
KHANA-KH.pdf | 2021-02-16 15:13 | 266K | ||
sti-q3-2009-pdf.jpg | 2021-02-27 08:45 | 264K | ||
sti-q2-2009-pdf.jpg | 2021-02-27 08:41 | 263K | ||
sti-q4-2008-pdf.jpg | 2021-02-28 08:05 | 262K | ||
Report-B-CoPCT-Annua..> | 2021-02-24 03:31 | 262K | ||
HBC-q3-2006-pdf.jpg | 2021-02-28 08:34 | 261K | ||
sti-q1-2009-pdf.jpg | 2021-02-27 08:37 | 260K | ||
ART-q4-2006.pdf | 2021-02-28 08:37 | 260K | ||
vcct-q3-2009-pdf.jpg | 2021-02-27 08:45 | 259K | ||
sti-q3-2008-pdf.jpg | 2021-02-28 08:02 | 254K | ||
hbc-q4-2009-pdf.jpg | 2021-02-27 09:00 | 252K | ||
hbc-q3-2009-pdf.jpg | 2021-02-27 08:44 | 251K | ||
DBS-HSS-KH.pdf | 2021-02-23 15:46 | 251K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 250K | ||
hbc-q1-2009-pdf.jpg | 2021-02-27 08:36 | 250K | ||
hbc-q2-2009-pdf.jpg | 2021-02-27 08:41 | 250K | ||
FHI-EN.pdf | 2021-02-16 15:17 | 249K | ||
LOA_-NCHADS_KHANA_20..> | 2021-02-16 14:39 | 247K | ||
HBC-q4-2006-pdf.jpg | 2021-02-28 08:37 | 244K | ||
HBC-q4-2007-pdf.jpg | 2021-02-28 08:18 | 243K | ||
STI-q2-2007-pdf.jpg | 2021-02-28 08:10 | 242K | ||
Standard-Protocol-Ba..> | 2021-02-17 03:47 | 239K | ||
art-q3-2007-pdf.jpg | 2021-02-28 08:12 | 238K | ||
ARV-guideline-2007-K..> | 2021-02-21 16:24 | 238K | ||
oi-q3-2007-pdf.jpg | 2021-02-28 08:12 | 238K | ||
linkresponse-q4-2009..> | 2021-02-27 09:00 | 237K | ||
HBC-q2-2006-pdf.jpg | 2021-02-28 08:31 | 231K | ||
Concept-Paper-in-Khm..> | 2021-02-23 15:21 | 230K | ||
VCCT-q1-2007-pdf.jpg | 2021-02-28 08:08 | 227K | ||
hbc-q4-2008-pdf.jpg | 2021-02-28 08:05 | 225K | ||
art-q2-2008-pdf.jpg | 2021-02-28 07:48 | 225K | ||
National-Guide-for-S..> | 2021-02-21 16:37 | 224K | ||
oi-q3-2009-pdf.jpg | 2021-02-27 08:45 | 219K | ||
art-q3-2008-pdf.jpg | 2021-02-28 08:01 | 218K | ||
Strategic-Plan-2004-..> | 2021-02-21 16:06 | 218K | ||
oi-q4-2009-pdf.jpg | 2021-02-27 09:00 | 218K | ||
art-q4-2008-pdf.jpg | 2021-02-28 08:05 | 218K | ||
VCCT-q4-2006-pdf.jpg | 2021-02-28 08:37 | 218K | ||
oi-q4-2008-pdf.jpg | 2021-02-28 08:05 | 217K | ||
oi-q3-2008-pdf.jpg | 2021-02-28 08:01 | 217K | ||
art-q1-2008-pdf.jpg | 2021-02-28 07:43 | 217K | ||
VCCT-q3-2006-pdf.jpg | 2021-02-28 08:34 | 215K | ||
Lost-to-Follow-up-Le..> | 2021-02-19 17:40 | 214K | ||
art-q3-2009-pdf.jpg | 2021-02-27 08:44 | 214K | ||
STI-q3-2007-pdf.jpg | 2021-02-28 08:13 | 214K | ||
ART-q2-2006-pdf-1024..> | 2021-02-28 08:31 | 213K | ||
New-Biological-Crite..> | 2021-02-20 16:35 | 213K | ||
art-q4-2009-pdf.jpg | 2021-02-27 09:00 | 213K | ||
oi-q1-2008-pdf.jpg | 2021-02-28 07:43 | 212K | ||
oi-q2-2008-pdf.jpg | 2021-02-28 07:48 | 210K | ||
OI-prophylaxis-Guide..> | 2021-02-21 16:34 | 210K | ||
guide2-pdf.jpg | 2021-02-21 09:36 | 210K | ||
OI-q4-2006-pdf.jpg | 2021-02-28 08:37 | 209K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 208K | ||
Policy-and-strategy-..> | 2021-02-21 16:15 | 208K | ||
art-q2-2009-pdf.jpg | 2021-02-27 08:41 | 208K | ||
tb-q3-2009-pdf.jpg | 2021-02-27 08:45 | 208K | ||
tb-q4-2009-pdf.jpg | 2021-02-27 09:00 | 207K | ||
oi-q2-2009-pdf.jpg | 2021-02-27 08:41 | 206K | ||
SOP-ORCUP-Eng.pdf | 2021-02-24 07:00 | 206K | ||
Guidance-to-the-Oper..> | 2021-02-19 17:12 | 205K | ||
linkresponse-q2-2009..> | 2021-02-27 08:41 | 205K | ||
ART-q4-2006-pdf.jpg | 2021-02-28 08:37 | 205K | ||
guideline-CD4350-pdf..> | 2021-02-21 15:56 | 203K | ||
VCCT-q3-2007.pdf | 2021-02-28 08:13 | 203K | ||
Rapid-assessment-kh-..> | 2021-02-28 16:02 | 202K | ||
approval-letter-for-..> | 2021-02-21 09:16 | 201K | ||
sti-q2-2008-pdf.jpg | 2021-02-28 07:48 | 201K | ||
TasP_NCHADS-Concept-..> | 2021-02-23 15:03 | 201K | ||
guide3-pdf.jpg | 2021-02-21 09:33 | 199K | ||
ART-q3-2006.pdf | 2021-02-28 08:34 | 199K | ||
Poligy-and-Guideline..> | 2021-02-21 16:30 | 198K | ||
Linked-Response-of-P..> | 2021-02-21 16:45 | 197K | ||
Female-worker-EN-pdf..> | 2021-02-23 15:28 | 197K | ||
art-q4-2007-pdf.jpg | 2021-02-28 08:18 | 196K | ||
DBS-HSS-KH-pdf.jpg | 2021-02-23 15:46 | 196K | ||
sti-q1-2008-pdf.jpg | 2021-02-28 07:43 | 196K | ||
ART-q1-2006-pdf-1024..> | 2021-02-28 08:23 | 195K | ||
oi-q4-2007-pdf.jpg | 2021-02-28 08:18 | 195K | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 195K | ||
ART-q3-2006-pdf.jpg | 2021-02-28 08:34 | 193K | ||
Linked-Response-of-P..> | 2021-02-21 16:45 | 193K | ||
VCCT-q1-2006-pdf-102..> | 2021-02-28 08:23 | 192K | ||
SOP-CQI-KH-pdf.jpg | 2021-02-17 07:56 | 191K | ||
VCCT-q2-2006-pdf-102..> | 2021-02-28 08:32 | 190K | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 190K | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 190K | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 190K | ||
SOP-Book_khm_V4-pdf.jpg | 2021-02-23 15:11 | 187K | ||
OI-q3-2006-pdf.jpg | 2021-02-28 08:34 | 186K | ||
VCCT_User_Manual-pdf..> | 2021-02-20 16:48 | 185K | ||
art-q1-2009-pdf-1024..> | 2021-02-27 08:36 | 184K | ||
STI-q4-2007-pdf.jpg | 2021-02-28 08:18 | 184K | ||
slides-sti-kh-pdf.jpg | 2021-02-16 15:39 | 183K | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 182K | ||
slides-sti-en-pdf.jpg | 2021-02-16 15:46 | 182K | ||
OI-q3-2006.pdf | 2021-02-28 08:34 | 182K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 181K | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 181K | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 181K | ||
Integrate-OVC-into-C..> | 2021-02-24 07:30 | 180K | ||
Guidance-to-enhance-..> | 2021-02-19 17:18 | 178K | ||
STI-q4-2006-pdf.jpg | 2021-02-28 08:37 | 176K | ||
VCCT-q4-2007-pdf-747..> | 2021-02-28 08:18 | 176K | ||
OI_ART_User_Manual-p..> | 2021-02-20 16:44 | 175K | ||
Standard-Protocol-Ba..> | 2021-02-17 03:54 | 174K | ||
DBS-HSS-EN.pdf | 2021-02-23 15:46 | 174K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 174K | ||
Concept-Paper-in-Eng..> | 2021-02-23 15:21 | 173K | ||
VCCT-q4-2006.pdf | 2021-02-28 08:37 | 172K | ||
SOP-logistic-KH.pdf | 2021-02-24 07:05 | 171K | ||
oi-q1-2009-pdf-1024x..> | 2021-02-27 08:37 | 171K | ||
OI-q2-2006-pdf-1024x..> | 2021-02-28 08:31 | 171K | ||
DBS-HSS-EN-pdf.jpg | 2021-02-23 15:46 | 169K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 168K | ||
SOP-ORCUP-KH-pdf.jpg | 2021-02-24 07:00 | 167K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 167K | ||
STD_User_Manual-pdf-..> | 2021-02-20 16:51 | 166K | ||
OI-q1-2006-pdf-1024x..> | 2021-02-28 08:23 | 166K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 165K | ||
Concept-paper-for-sy..> | 2021-02-23 15:25 | 163K | ||
vcct-q2-2008-pdf-102..> | 2021-02-28 07:48 | 162K | ||
linkresponse-q1-2009..> | 2021-02-27 08:36 | 162K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 162K | ||
KHANA-EN.pdf | 2021-02-16 15:13 | 161K | ||
SOP-Book_EN_V4-pdf.jpg | 2021-02-23 15:10 | 161K | ||
vcct-q4-2009-pdf-102..> | 2021-02-27 09:00 | 158K | ||
vcct-q1-2008-pdf-725..> | 2021-02-28 07:43 | 158K | ||
positive-prevention-..> | 2021-02-21 09:18 | 158K | ||
vcct-q3-2008-pdf-745..> | 2021-02-28 08:02 | 157K | ||
Integrate-OVC-into-C..> | 2021-02-24 07:30 | 157K | ||
vcct-q4-2008-pdf-745..> | 2021-02-28 08:05 | 156K | ||
ACM_Book-2013-pdf.jpg | 2021-02-20 16:40 | 156K | ||
linkresponse-q3-2009..> | 2021-02-27 08:45 | 156K | ||
vcct-q3-2009-pdf-102..> | 2021-02-27 08:45 | 156K | ||
OI-q4-2006.pdf | 2021-02-28 08:37 | 155K | ||
hbc-q4-2009-pdf-1024..> | 2021-02-27 09:00 | 155K | ||
SOP-mmm-EN-pdf.jpg | 2021-02-23 15:33 | 154K | ||
positive-prevention-..> | 2021-02-21 09:18 | 154K | ||
hbc-q3-2009-pdf-1024..> | 2021-02-27 08:44 | 154K | ||
vcct-q1-2009-pdf-729..> | 2021-02-27 08:37 | 154K | ||
EWI-2008-2010-pdf.jpg | 2021-02-28 15:59 | 153K | ||
hbc-q1-2009-pdf-1024..> | 2021-02-27 08:36 | 153K | ||
CQI_dashboard_usergu..> | 2021-02-20 16:54 | 153K | ||
SOP-KH-pdf-1.jpg | 2021-02-24 07:02 | 152K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 152K | ||
hbc-q2-2008-pdf-1024..> | 2021-02-28 07:48 | 151K | ||
hbc-q1-2008-pdf-1024..> | 2021-02-28 07:43 | 151K | ||
hbc-q2-2009-pdf-1024..> | 2021-02-27 08:41 | 151K | ||
Female-worker-KH-pdf..> | 2021-02-23 15:28 | 151K | ||
vcct-q2-2009-pdf-725..> | 2021-02-27 08:41 | 151K | ||
HBC-q1-2007-pdf-712x..> | 2021-02-28 08:08 | 151K | ||
Report-B-CoPCT-Annua..> | 2021-02-24 03:31 | 150K | ||
HBC-q4-2007-pdf-1024..> | 2021-02-28 08:18 | 149K | ||
VCCT-q3-2007-pdf-102..> | 2021-02-28 08:13 | 147K | ||
HBC-q2-2007-pdf-1024..> | 2021-02-28 08:10 | 147K | ||
HBC-q3-2007-pdf-1024..> | 2021-02-28 08:12 | 147K | ||
VCCT-q2-2007-pdf-102..> | 2021-02-28 08:10 | 146K | ||
HSS_2010-Report-pdf.jpg | 2021-02-15 15:52 | 146K | ||
HBC-q4-2006-pdf-1024..> | 2021-02-28 08:37 | 143K | ||
Policy-and-strategy-..> | 2021-02-21 16:15 | 143K | ||
LOA-NCHADS-and-CPN-p..> | 2021-02-21 16:21 | 142K | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 141K | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 141K | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 141K | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:48 | 140K | ||
National-Guidelines-..> | 2021-02-19 17:30 | 140K | ||
Guidance-to-enhance-..> | 2021-02-19 17:20 | 140K | ||
D4T-Phasing-Out-KH-p..> | 2021-02-17 07:28 | 140K | ||
HBC-q3-2006.pdf | 2021-02-28 08:34 | 139K | ||
Guidance-to-the-Oper..> | 2021-02-19 17:11 | 139K | ||
National-Guidelines-..> | 2021-02-21 16:43 | 139K | ||
KHANA-EN-pdf.jpg | 2021-02-16 15:13 | 136K | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:49 | 135K | ||
SOP-TB-and-HIV-ENG-p..> | 2021-02-24 06:46 | 135K | ||
RACHA-KH-pdf.jpg | 2021-02-16 15:22 | 135K | ||
hbc-q4-2008-pdf-1024..> | 2021-02-28 08:05 | 134K | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 134K | ||
sti-q4-2009-pdf-724x..> | 2021-02-27 09:00 | 133K | ||
HBC-q2-2006-pdf-1024..> | 2021-02-28 08:31 | 133K | ||
sti-q4-2008-pdf-724x..> | 2021-02-28 08:05 | 131K | ||
HBC-q3-2006-pdf-724x..> | 2021-02-28 08:34 | 130K | ||
SOP-CoPCT-KH-pdf.jpg | 2021-02-17 08:31 | 130K | ||
Book-CoPCT-Kh-pdf.jpg | 2021-02-22 15:33 | 130K | ||
Letter-of-Agreement-..> | 2021-02-16 09:13 | 130K | ||
sti-q3-2009-pdf-724x..> | 2021-02-27 08:45 | 130K | ||
sti-q1-2009-pdf-724x..> | 2021-02-27 08:37 | 129K | ||
National-Guide-on-ST..> | 2021-02-21 16:40 | 129K | ||
RACHA-EN-pdf.jpg | 2021-02-16 15:22 | 128K | ||
sti-q2-2009-pdf-724x..> | 2021-02-27 08:41 | 128K | ||
SOP-EN-pdf-1.jpg | 2021-02-24 07:02 | 128K | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 128K | ||
sti-q3-2008-pdf-744x..> | 2021-02-28 08:02 | 127K | ||
SOP-for-MMM-KHM-pdf.jpg | 2021-02-24 06:48 | 127K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 127K | ||
Rapid-assessment-kh-..> | 2021-02-28 16:02 | 126K | ||
linkresponse-q2-2009..> | 2021-02-27 08:41 | 126K | ||
SOP-for-HBC-KHM-pdf.jpg | 2021-02-24 06:54 | 126K | ||
National-Guidelines-..> | 2021-02-20 16:59 | 126K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 124K | ||
STI-q2-2007-pdf-745x..> | 2021-02-28 08:10 | 124K | ||
OI-prophylaxis-Guide..> | 2021-02-21 16:34 | 124K | ||
SOP-mmm-KH-pdf.jpg | 2021-02-23 15:33 | 123K | ||
SOP-Book_khm_V4-pdf-..> | 2021-02-23 15:11 | 123K | ||
LOA_-NCHADS_KHANA_20..> | 2021-02-16 14:39 | 123K | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 122K | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 122K | ||
STI-Sentinel-Survey-..> | 2021-02-28 09:17 | 121K | ||
ARV-guideline-2007-K..> | 2021-02-21 16:24 | 121K | ||
VCCT-q1-2007-pdf-711..> | 2021-02-28 08:08 | 120K | ||
SOP-ORCUP-Eng-pdf.jpg | 2021-02-24 07:00 | 120K | ||
National-Consolidate..> | 2021-02-19 17:37 | 119K | ||
SOP-CQI-EN-pdf.jpg | 2021-02-17 08:01 | 119K | ||
art-q3-2007-pdf-725x..> | 2021-02-28 08:12 | 117K | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 117K | ||
art-q2-2008-pdf-736x..> | 2021-02-28 07:48 | 117K | ||
Agreement_NCHADSNBTC..> | 2021-02-16 09:26 | 117K | ||
Guidline-screening-o..> | 2021-02-16 06:50 | 117K | ||
SOP-for-MMM-ENG-pdf.jpg | 2021-02-24 06:48 | 117K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 116K | ||
VCCT-q4-2006-pdf-744..> | 2021-02-28 08:37 | 116K | ||
psf_ci-pdf.jpg | 2021-02-16 14:59 | 116K | ||
National_Guideline_S..> | 2021-02-15 09:26 | 116K | ||
MHS-EN-pdf.jpg | 2021-02-16 14:45 | 115K | ||
Strategic-Plan-2004-..> | 2021-02-21 16:06 | 115K | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 115K | ||
FHI-EN-pdf.jpg | 2021-02-16 15:17 | 115K | ||
art-q4-2008-pdf-748x..> | 2021-02-28 08:05 | 115K | ||
oi-q3-2007-pdf-725x1..> | 2021-02-28 08:12 | 114K | ||
oi-q4-2009-pdf-725x1..> | 2021-02-27 09:00 | 114K | ||
FHI-KH-pdf.jpg | 2021-02-16 15:17 | 114K | ||
oi-q4-2008-pdf-748x1..> | 2021-02-28 08:05 | 114K | ||
SOP-Book_EN_V4-pdf-7..> | 2021-02-23 15:10 | 113K | ||
art-q3-2009-pdf-725x..> | 2021-02-27 08:44 | 113K | ||
STI-q4-2006-pdf-791x..> | 2021-02-28 08:37 | 113K | ||
art-q1-2008-pdf-745x..> | 2021-02-28 07:43 | 113K | ||
tb-q3-2009-pdf-791x1..> | 2021-02-27 08:45 | 112K | ||
art-q3-2008-pdf-745x..> | 2021-02-28 08:01 | 112K | ||
core-indicator-kh-pd..> | 2021-02-21 16:13 | 112K | ||
Concept-Paper-in-Khm..> | 2021-02-23 15:21 | 112K | ||
oi-q3-2008-pdf-745x1..> | 2021-02-28 08:01 | 111K | ||
Standard-Protocol-Ba..> | 2021-02-17 03:47 | 111K | ||
oi-q3-2009-pdf-725x1..> | 2021-02-27 08:45 | 111K | ||
art-q4-2009-pdf-725x..> | 2021-02-27 09:00 | 110K | ||
oi-q1-2008-pdf-745x1..> | 2021-02-28 07:43 | 110K | ||
oi-q2-2008-pdf-740x1..> | 2021-02-28 07:48 | 109K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 109K | ||
TasP_NCHADS-Concept-..> | 2021-02-23 15:03 | 109K | ||
National-Guide-for-S..> | 2021-02-21 16:37 | 109K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 109K | ||
art-q2-2009-pdf-745x..> | 2021-02-27 08:41 | 108K | ||
tb-q4-2009-pdf-725x1..> | 2021-02-27 09:00 | 108K | ||
OI-q4-2006-pdf-744x1..> | 2021-02-28 08:37 | 107K | ||
ART-q4-2006-pdf-744x..> | 2021-02-28 08:37 | 107K | ||
VCCT-q3-2006-pdf-724..> | 2021-02-28 08:34 | 107K | ||
MHS-KH-pdf.jpg | 2021-02-16 14:45 | 107K | ||
STI-q4-2007-pdf-791x..> | 2021-02-28 08:18 | 106K | ||
D4T-Phasing-Out-EN-p..> | 2021-02-17 07:32 | 106K | ||
Female-worker-EN-pdf..> | 2021-02-23 15:28 | 106K | ||
oi-q2-2009-pdf-745x1..> | 2021-02-27 08:41 | 106K | ||
guide2-pdf-725x1024.jpg | 2021-02-21 09:36 | 106K | ||
Linked-Response-of-P..> | 2021-02-21 16:45 | 106K | ||
New-Biological-Crite..> | 2021-02-20 16:35 | 104K | ||
STI-q3-2007-pdf-739x..> | 2021-02-28 08:13 | 104K | ||
LOA_NCHADS_CRS-pdf.jpg | 2021-02-16 15:10 | 104K | ||
HBC-q2-2006.pdf | 2021-02-28 08:31 | 104K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 104K | ||
SOP-CDC-KH-pdf.jpg | 2021-02-24 07:22 | 103K | ||
Lost-to-Follow-up-Le..> | 2021-02-19 17:40 | 103K | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 103K | ||
ARV-guideline-2007-E..> | 2021-02-21 16:23 | 102K | ||
guideline-CD4350-pdf..> | 2021-02-21 15:56 | 102K | ||
slides-sti-en-pdf-10..> | 2021-02-16 15:46 | 101K | ||
ARV-Guideline-2005-E..> | 2021-02-21 16:28 | 101K | ||
approval-letter-for-..> | 2021-02-21 09:16 | 101K | ||
Guidance-to-the-Oper..> | 2021-02-19 17:12 | 101K | ||
art-q4-2007-pdf-745x..> | 2021-02-28 08:18 | 100K | ||
SOP-for-HBC-ENG-pdf.jpg | 2021-02-24 06:54 | 100K | ||
ART-q3-2006-pdf-724x..> | 2021-02-28 08:34 | 100K | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 99K | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 99K | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 99K | ||
SOP-CQI-KH-pdf-724x1..> | 2021-02-17 07:56 | 99K | ||
sti-q2-2008-pdf-734x..> | 2021-02-28 07:48 | 99K | ||
guide3-pdf-725x1024.jpg | 2021-02-21 09:33 | 98K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 98K | ||
SOP-Kh-pdf.jpg | 2021-02-24 06:39 | 98K | ||
Agreement-Nchads-Mag..> | 2021-02-15 15:36 | 97K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 97K | ||
OI-q3-2006-pdf-724x1..> | 2021-02-28 08:34 | 97K | ||
SOP-for-PBSI-KH-pdf.jpg | 2021-02-24 06:41 | 97K | ||
oi-q4-2007-pdf-745x1..> | 2021-02-28 08:18 | 96K | ||
sti-q1-2008-pdf-724x..> | 2021-02-28 07:43 | 96K | ||
slides-sti-kh-pdf-10..> | 2021-02-16 15:39 | 96K | ||
Agreement-NCHADS-AHF..> | 2021-02-16 14:28 | 95K | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 95K | ||
ACM_Book-2013-pdf-70..> | 2021-02-20 16:40 | 95K | ||
core-indicator-en-pd..> | 2021-02-21 16:12 | 94K | ||
LOA_NCHADS_worldvisi..> | 2021-02-16 15:04 | 94K | ||
BIACM-Anual-Report-2..> | 2021-02-24 04:41 | 94K | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 94K | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 94K | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 94K | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 94K | ||
DBS-HSS-KH-pdf-724x1..> | 2021-02-23 15:46 | 93K | ||
SOP-CoPCT-EN-pdf.jpg | 2021-02-17 08:44 | 93K | ||
Book-CoPCT-English-p..> | 2021-02-22 15:30 | 93K | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 93K | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:13 | 93K | ||
HBC-q1-2007.pdf | 2021-02-28 08:08 | 93K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 93K | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 93K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 92K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 92K | ||
SOP-for-PBSI-EN-pdf.jpg | 2021-02-24 06:41 | 91K | ||
Integrate-OVC-into-C..> | 2021-02-24 07:30 | 91K | ||
National-Guideline-f..> | 2021-02-21 16:19 | 91K | ||
sop-coc-08-kh-pdf.jpg | 2021-02-23 15:35 | 90K | ||
SOP-En-pdf.jpg | 2021-02-24 06:39 | 89K | ||
SOP-mmm-EN-pdf-791x1..> | 2021-02-23 15:33 | 89K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 88K | ||
National-Consolidate..> | 2021-02-19 17:37 | 88K | ||
ARV-guideline-2005-K..> | 2021-02-21 16:28 | 88K | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 87K | ||
Guidance-to-enhance-..> | 2021-02-19 17:18 | 87K | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 86K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 86K | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 85K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 85K | ||
DBS-HSS-EN-pdf-724x1..> | 2021-02-23 15:46 | 85K | ||
Concept-Paper-in-Eng..> | 2021-02-23 15:21 | 85K | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 85K | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 85K | ||
sop-coc-08-en-pdf.jpg | 2021-02-23 15:35 | 85K | ||
Adult_HIV_Management..> | 2021-02-16 06:39 | 84K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 84K | ||
positive-prevention-..> | 2021-02-21 09:18 | 83K | ||
SOP-ORCUP-KH-pdf-724..> | 2021-02-24 07:00 | 83K | ||
SOP-logistic-KH-pdf.jpg | 2021-02-24 07:05 | 83K | ||
SOP-KH-pdf-1-791x102..> | 2021-02-24 07:02 | 82K | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 81K | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 81K | ||
KHANA-EN-pdf-791x102..> | 2021-02-16 15:13 | 81K | ||
positive-prevention-..> | 2021-02-21 09:18 | 81K | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:12 | 81K | ||
SOP-for-NCHADS-PBSI-..> | 2021-02-23 15:42 | 80K | ||
SOP-for-Social-Care-..> | 2021-02-24 07:33 | 80K | ||
STI-Sentinel-Survey-..> | 2021-02-28 09:17 | 80K | ||
Standard-Protocol-Ba..> | 2021-02-17 03:54 | 80K | ||
Concept-paper-for-sy..> | 2021-02-23 15:25 | 78K | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 77K | ||
report-ewi-2011-pdf.jpg | 2021-02-28 15:54 | 75K | ||
HSS_2010-Report-pdf-..> | 2021-02-15 15:52 | 75K | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 75K | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 74K | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 74K | ||
LOA-NCHADS-and-CPN-p..> | 2021-02-21 16:21 | 73K | ||
Guidance-to-the-Oper..> | 2021-02-19 17:11 | 73K | ||
National-Guidelines-..> | 2021-02-19 17:30 | 72K | ||
EWI-2008-2010-pdf-10..> | 2021-02-28 15:59 | 72K | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 72K | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 72K | ||
D4T-Phasing-Out-KH-p..> | 2021-02-17 07:28 | 72K | ||
National-Consolidate..> | 2021-02-19 17:37 | 71K | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 71K | ||
SOP-Book_khm_V4-pdf-..> | 2021-02-23 15:11 | 71K | ||
Policy-and-strategy-..> | 2021-02-21 16:15 | 71K | ||
OI-prophylaxis-Guide..> | 2021-02-21 16:34 | 70K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 70K | ||
RACHA-EN-pdf-725x102..> | 2021-02-16 15:22 | 70K | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:48 | 70K | ||
SOP-Book_EN_V4-pdf-2..> | 2021-02-23 15:10 | 69K | ||
SOP-EN-pdf-1-791x102..> | 2021-02-24 07:02 | 69K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 69K | ||
RACHA-KH-pdf-725x102..> | 2021-02-16 15:22 | 69K | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:49 | 68K | ||
National-Guidelines-..> | 2021-02-20 16:59 | 68K | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 68K | ||
FHI-EN-pdf-791x1024.jpg | 2021-02-16 15:17 | 68K | ||
SOP-mmm-KH-pdf-791x1..> | 2021-02-23 15:33 | 67K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 67K | ||
Poligy-and-Guideline..> | 2021-02-21 16:30 | 67K | ||
SOP-ORCUP-Eng-pdf-79..> | 2021-02-24 07:00 | 66K | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 66K | ||
Letter-of-Agreement-..> | 2021-02-16 09:13 | 66K | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 66K | ||
SOP-CoPCT-KH-pdf-724..> | 2021-02-17 08:31 | 66K | ||
Book-CoPCT-Kh-pdf-72..> | 2021-02-22 15:33 | 66K | ||
KHANA-KH-pdf.jpg | 2021-02-16 15:13 | 66K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 66K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 65K | ||
SOP-Book_khm_V4-pdf-..> | 2021-02-23 15:11 | 65K | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 65K | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 65K | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 65K | ||
SOP-for-MMM-KHM-pdf-..> | 2021-02-24 06:48 | 65K | ||
National-Guidelines-..> | 2021-02-20 16:59 | 65K | ||
SOP-Book_EN_V4-pdf-1..> | 2021-02-23 15:10 | 65K | ||
SOP-for-HBC-KHM-pdf-..> | 2021-02-24 06:54 | 64K | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 64K | ||
psf_ci-pdf-725x1024.jpg | 2021-02-16 14:59 | 63K | ||
National-Guidelines-..> | 2021-02-19 17:30 | 63K | ||
OI-Guideline-Booklet..> | 2021-02-21 16:33 | 63K | ||
SOP-for-MMM-ENG-pdf-..> | 2021-02-24 06:48 | 63K | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 63K | ||
SOP-logistic-EN-pdf.jpg | 2021-02-24 07:05 | 62K | ||
MHS-EN-pdf-724x1024.jpg | 2021-02-16 14:45 | 62K | ||
LOA_NCHADS_CRS-pdf-7..> | 2021-02-16 15:10 | 62K | ||
National-Guide-on-ST..> | 2021-02-21 16:40 | 62K | ||
National_Guideline_S..> | 2021-02-15 09:26 | 62K | ||
SOP-CQI-EN-pdf-724x1..> | 2021-02-17 08:01 | 61K | ||
Adult_HIV_Management..> | 2021-02-16 06:38 | 61K | ||
core-indicator-kh-pd..> | 2021-02-21 16:13 | 61K | ||
FHI-KH-pdf-724x1024.jpg | 2021-02-16 15:17 | 58K | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 58K | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 58K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 57K | ||
Agreement_NCHADSNBTC..> | 2021-02-16 09:26 | 57K | ||
National-Consolidate..> | 2021-02-19 17:37 | 56K | ||
MHS-KH-pdf-724x1024.jpg | 2021-02-16 14:45 | 56K | ||
D4T-Phasing-Out-EN-p..> | 2021-02-17 07:32 | 56K | ||
BIACM-Anual-Report-2..> | 2021-02-24 04:41 | 55K | ||
HBC-q4-2006.pdf | 2021-02-28 08:37 | 54K | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 54K | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 54K | ||
Strategic-Plan-2001-..> | 2021-02-21 16:09 | 54K | ||
LOA_NCHADS_worldvisi..> | 2021-02-16 15:04 | 53K | ||
core-indicator-en-pd..> | 2021-02-21 16:12 | 53K | ||
ARV-guideline-2007-E..> | 2021-02-21 16:23 | 52K | ||
SOP-for-PBSI-EN-pdf-..> | 2021-02-24 06:41 | 52K | ||
SOP-for-Social-Care-..> | 2021-02-24 07:33 | 52K | ||
ARV-Guideline-2005-E..> | 2021-02-21 16:28 | 52K | ||
SOP-for-HBC-ENG-pdf-..> | 2021-02-24 06:54 | 52K | ||
SOP-CDC-KH-pdf-724x1..> | 2021-02-24 07:22 | 51K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 51K | ||
SOP-for-PBSI-KH-pdf-..> | 2021-02-24 06:41 | 51K | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 51K | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 50K | ||
Guidline-screening-o..> | 2021-02-16 06:49 | 50K | ||
SOP-CoPCT-EN-pdf-724..> | 2021-02-17 08:44 | 50K | ||
Book-CoPCT-English-p..> | 2021-02-22 15:30 | 50K | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 50K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 50K | ||
Agreement-Nchads-Mag..> | 2021-02-15 15:36 | 50K | ||
Guidline-screening-o..> | 2021-02-16 06:50 | 49K | ||
SOP-En-pdf-724x1024.jpg | 2021-02-24 06:39 | 49K | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 49K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 48K | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:13 | 47K | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 47K | ||
National-Guideline-f..> | 2021-02-21 16:19 | 47K | ||
SOP-Kh-pdf-724x1024.jpg | 2021-02-24 06:39 | 47K | ||
Agreement-NCHADS-AHF..> | 2021-02-16 14:28 | 47K | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 46K | ||
SOP-for-NCHADS-PBSI-..> | 2021-02-23 15:42 | 45K | ||
sop-coc-08-kh-pdf-72..> | 2021-02-23 15:35 | 44K | ||
report-ewi-2011-pdf-..> | 2021-02-28 15:54 | 43K | ||
ARV-guideline-2005-K..> | 2021-02-21 16:28 | 42K | ||
SOP-logistic-KH-pdf-..> | 2021-02-24 07:05 | 42K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 42K | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 42K | ||
Adult_HIV_Management..> | 2021-02-16 06:39 | 41K | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 41K | ||
sop-coc-08-en-pdf-72..> | 2021-02-23 15:35 | 41K | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:12 | 40K | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 39K | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 38K | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 38K | ||
KHANA-KH-pdf-791x102..> | 2021-02-16 15:13 | 38K | ||
National-Guidelines-..> | 2021-02-20 16:59 | 37K | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 37K | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 37K | ||
SOP-logistic-EN-pdf-..> | 2021-02-24 07:05 | 37K | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 36K | ||
Adult_HIV_Management..> | 2021-02-16 06:38 | 35K | ||
Poligy-and-Guideline..> | 2021-02-21 16:30 | 35K | ||
OI-Guideline-Booklet..> | 2021-02-21 16:33 | 32K | ||
Strategic-Plan-2001-..> | 2021-02-21 16:09 | 30K | ||
linkresponse-q4-2009..> | 2021-02-27 09:00 | 29K | ||
ART-q2-2006-pdf-300x..> | 2021-02-28 08:31 | 28K | ||
art-q1-2009-pdf-300x..> | 2021-02-27 08:36 | 27K | ||
OI-q2-2006-pdf-300x2..> | 2021-02-28 08:31 | 26K | ||
Guidline-screening-o..> | 2021-02-16 06:49 | 25K | ||
oi-q1-2009-pdf-300x2..> | 2021-02-27 08:37 | 25K | ||
VCCT-q2-2006-pdf-300..> | 2021-02-28 08:32 | 25K | ||
VCCT-q1-2006-pdf-300..> | 2021-02-28 08:23 | 25K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 23K | ||
HBC-q4-2006-pdf-300x..> | 2021-02-28 08:37 | 23K | ||
Female-worker-KH-pdf..> | 2021-02-23 15:28 | 23K | ||
hbc-q4-2009-pdf-300x..> | 2021-02-27 09:00 | 23K | ||
ART-q1-2006-pdf-300x..> | 2021-02-28 08:23 | 22K | ||
hbc-q4-2008-pdf-300x..> | 2021-02-28 08:05 | 22K | ||
hbc-q2-2009-pdf-300x..> | 2021-02-27 08:41 | 22K | ||
Guidance-to-enhance-..> | 2021-02-19 17:20 | 22K | ||
hbc-q1-2009-pdf-300x..> | 2021-02-27 08:36 | 22K | ||
OI-q1-2006-pdf-300x2..> | 2021-02-28 08:23 | 22K | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 22K | ||
HBC-q4-2007-pdf-300x..> | 2021-02-28 08:18 | 22K | ||
VCCT_User_Manual-pdf..> | 2021-02-20 16:48 | 22K | ||
HBC-q2-2006-pdf-300x..> | 2021-02-28 08:31 | 21K | ||
STI-q4-2006-pdf-232x..> | 2021-02-28 08:37 | 21K | ||
linkresponse-q2-2009..> | 2021-02-27 08:41 | 21K | ||
VCCT-q3-2007-pdf-300..> | 2021-02-28 08:13 | 21K | ||
vcct-q2-2008-pdf-300..> | 2021-02-28 07:48 | 21K | ||
HBC-q1-2007-pdf-209x..> | 2021-02-28 08:08 | 21K | ||
VCCT-q4-2007-pdf-219..> | 2021-02-28 08:18 | 20K | ||
sti-q4-2009-pdf-212x..> | 2021-02-27 09:00 | 20K | ||
vcct-q4-2009-pdf-300..> | 2021-02-27 09:00 | 20K | ||
hbc-q3-2009-pdf-300x..> | 2021-02-27 08:44 | 20K | ||
VCCT-q2-2007-pdf-300..> | 2021-02-28 08:10 | 20K | ||
sti-q4-2008-pdf-212x..> | 2021-02-28 08:05 | 20K | ||
vcct-q2-2009-pdf-212..> | 2021-02-27 08:41 | 20K | ||
hbc-q2-2008-pdf-300x..> | 2021-02-28 07:48 | 20K | ||
hbc-q1-2008-pdf-300x..> | 2021-02-28 07:43 | 20K | ||
vcct-q3-2008-pdf-218..> | 2021-02-28 08:02 | 20K | ||
OI_ART_User_Manual-p..> | 2021-02-20 16:44 | 20K | ||
vcct-q4-2008-pdf-218..> | 2021-02-28 08:05 | 20K | ||
HBC-q2-2007-pdf-300x..> | 2021-02-28 08:10 | 20K | ||
HBC-q3-2007-pdf-300x..> | 2021-02-28 08:12 | 20K | ||
Report-B-CoPCT-Annua..> | 2021-02-24 03:31 | 20K | ||
vcct-q3-2009-pdf-300..> | 2021-02-27 08:45 | 19K | ||
vcct-q1-2008-pdf-212..> | 2021-02-28 07:43 | 19K | ||
CQI_dashboard_usergu..> | 2021-02-20 16:54 | 19K | ||
National-Guidelines-..> | 2021-02-21 16:43 | 19K | ||
slides-sti-en-pdf-30..> | 2021-02-16 15:46 | 19K | ||
ARV-guideline-2007-K..> | 2021-02-21 16:24 | 19K | ||
Strategic-Plan-2004-..> | 2021-02-21 16:06 | 19K | ||
STD_User_Manual-pdf-..> | 2021-02-20 16:51 | 18K | ||
oi-q4-2009-pdf-212x3..> | 2021-02-27 09:00 | 18K | ||
sti-q1-2009-pdf-212x..> | 2021-02-27 08:37 | 18K | ||
sti-q2-2009-pdf-212x..> | 2021-02-27 08:41 | 18K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 18K | ||
vcct-q1-2009-pdf-214..> | 2021-02-27 08:37 | 18K | ||
Rapid-assessment-kh-..> | 2021-02-28 16:02 | 18K | ||
sti-q3-2009-pdf-212x..> | 2021-02-27 08:45 | 18K | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 18K | ||
VCCT-q4-2006-pdf-218..> | 2021-02-28 08:37 | 18K | ||
linkresponse-q1-2009..> | 2021-02-27 08:36 | 18K | ||
STI-q2-2007-pdf-218x..> | 2021-02-28 08:10 | 18K | ||
art-q4-2008-pdf-219x..> | 2021-02-28 08:05 | 17K | ||
VCCT-q1-2007-pdf-208..> | 2021-02-28 08:08 | 17K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 17K | ||
art-q2-2008-pdf-216x..> | 2021-02-28 07:48 | 17K | ||
art-q4-2009-pdf-212x..> | 2021-02-27 09:00 | 17K | ||
oi-q1-2008-pdf-218x3..> | 2021-02-28 07:43 | 17K | ||
art-q3-2009-pdf-212x..> | 2021-02-27 08:44 | 17K | ||
oi-q3-2009-pdf-212x3..> | 2021-02-27 08:45 | 17K | ||
HBC-q3-2006-pdf-212x..> | 2021-02-28 08:34 | 17K | ||
art-q1-2008-pdf-218x..> | 2021-02-28 07:43 | 17K | ||
National-Guide-for-S..> | 2021-02-21 16:37 | 17K | ||
oi-q4-2008-pdf-219x3..> | 2021-02-28 08:05 | 17K | ||
Linked-Response-of-P..> | 2021-02-21 16:45 | 17K | ||
art-q3-2007-pdf-212x..> | 2021-02-28 08:12 | 17K | ||
art-q3-2008-pdf-218x..> | 2021-02-28 08:01 | 17K | ||
oi-q3-2008-pdf-218x3..> | 2021-02-28 08:01 | 17K | ||
art-q2-2009-pdf-218x..> | 2021-02-27 08:41 | 17K | ||
linkresponse-q3-2009..> | 2021-02-27 08:45 | 17K | ||
ART-q4-2006-pdf-218x..> | 2021-02-28 08:37 | 17K | ||
STI-q4-2007-pdf-232x..> | 2021-02-28 08:18 | 17K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 17K | ||
Female-worker-EN-pdf..> | 2021-02-23 15:28 | 17K | ||
oi-q2-2009-pdf-218x3..> | 2021-02-27 08:41 | 16K | ||
SOP-CQI-KH-pdf-212x3..> | 2021-02-17 07:56 | 16K | ||
OI-q4-2006-pdf-218x3..> | 2021-02-28 08:37 | 16K | ||
oi-q3-2007-pdf-212x3..> | 2021-02-28 08:12 | 16K | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 16K | ||
DBS-HSS-KH-pdf-212x3..> | 2021-02-23 15:46 | 16K | ||
oi-q2-2008-pdf-217x3..> | 2021-02-28 07:48 | 16K | ||
SOP-mmm-EN-pdf-232x3..> | 2021-02-23 15:33 | 16K | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 16K | ||
guide2-pdf-212x300.jpg | 2021-02-21 09:36 | 16K | ||
DBS-HSS-EN-pdf-212x3..> | 2021-02-23 15:46 | 16K | ||
slides-sti-kh-pdf-30..> | 2021-02-16 15:39 | 16K | ||
Integrate-OVC-into-C..> | 2021-02-24 07:30 | 16K | ||
positive-prevention-..> | 2021-02-21 09:18 | 16K | ||
tb-q3-2009-pdf-232x3..> | 2021-02-27 08:45 | 16K | ||
Concept-Paper-in-Khm..> | 2021-02-23 15:21 | 16K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 15K | ||
LOA_-NCHADS_KHANA_20..> | 2021-02-16 14:39 | 15K | ||
TasP_NCHADS-Concept-..> | 2021-02-23 15:03 | 15K | ||
tb-q4-2009-pdf-212x3..> | 2021-02-27 09:00 | 15K | ||
Guidance-to-enhance-..> | 2021-02-19 17:18 | 15K | ||
positive-prevention-..> | 2021-02-21 09:18 | 15K | ||
Guidance-to-the-Oper..> | 2021-02-19 17:12 | 15K | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 15K | ||
STI-Sentinel-Survey-..> | 2021-02-28 09:17 | 15K | ||
SOP-ORCUP-KH-pdf-212..> | 2021-02-24 07:00 | 15K | ||
art-q4-2007-pdf-218x..> | 2021-02-28 08:18 | 15K | ||
Standard-Protocol-Ba..> | 2021-02-17 03:47 | 15K | ||
oi-q4-2007-pdf-218x3..> | 2021-02-28 08:18 | 15K | ||
LOA-NCHADS-and-CPN-p..> | 2021-02-21 16:21 | 15K | ||
approval-letter-for-..> | 2021-02-21 09:16 | 15K | ||
KHANA-EN-pdf-232x300..> | 2021-02-16 15:13 | 15K | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 15K | ||
sti-q1-2008-pdf-212x..> | 2021-02-28 07:43 | 14K | ||
sti-q3-2008-pdf-218x..> | 2021-02-28 08:02 | 14K | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 14K | ||
STI-q3-2007-pdf-217x..> | 2021-02-28 08:13 | 14K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 14K | ||
SOP-KH-pdf-1-232x300..> | 2021-02-24 07:02 | 14K | ||
New-Biological-Crite..> | 2021-02-20 16:35 | 14K | ||
SOP-TB-and-HIV-ENG-p..> | 2021-02-24 06:46 | 14K | ||
guideline-CD4350-pdf..> | 2021-02-21 15:56 | 14K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 14K | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 14K | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 14K | ||
RACHA-EN-pdf-212x300..> | 2021-02-16 15:22 | 14K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 14K | ||
VCCT-q3-2006-pdf-212..> | 2021-02-28 08:34 | 14K | ||
guide3-pdf-212x300.jpg | 2021-02-21 09:33 | 14K | ||
ACM_Book-2013-pdf-20..> | 2021-02-20 16:40 | 14K | ||
OI-prophylaxis-Guide..> | 2021-02-21 16:34 | 14K | ||
RACHA-KH-pdf-212x300..> | 2021-02-16 15:22 | 14K | ||
SOP-for-MMM-ENG-pdf-..> | 2021-02-24 06:48 | 14K | ||
National-Consolidate..> | 2021-02-19 17:37 | 14K | ||
FHI-EN-pdf-232x300.jpg | 2021-02-16 15:17 | 13K | ||
National-Guidelines-..> | 2021-02-19 17:30 | 13K | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 13K | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 13K | ||
Lost-to-Follow-up-Le..> | 2021-02-19 17:40 | 13K | ||
National_Guideline_S..> | 2021-02-15 09:26 | 13K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 13K | ||
D4T-Phasing-Out-KH-p..> | 2021-02-17 07:28 | 13K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 13K | ||
Concept-Paper-in-Eng..> | 2021-02-23 15:21 | 13K | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 13K | ||
SOP-mmm-KH-pdf-232x3..> | 2021-02-23 15:33 | 13K | ||
SOP-EN-pdf-1-232x300..> | 2021-02-24 07:02 | 13K | ||
Policy-and-strategy-..> | 2021-02-21 16:15 | 13K | ||
SOP-for-MMM-KHM-pdf-..> | 2021-02-24 06:48 | 13K | ||
National-Guidelines-..> | 2021-02-20 16:59 | 13K | ||
SOP-for-HBC-KHM-pdf-..> | 2021-02-24 06:54 | 13K | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:49 | 13K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 13K | ||
National-Guidelines-..> | 2021-02-19 17:30 | 13K | ||
ART-q3-2006-pdf-212x..> | 2021-02-28 08:34 | 13K | ||
MHS-EN-pdf-212x300.jpg | 2021-02-16 14:45 | 13K | ||
sti-q2-2008-pdf-215x..> | 2021-02-28 07:48 | 13K | ||
psf_ci-pdf-212x300.jpg | 2021-02-16 14:59 | 13K | ||
SOP-ORCUP-Eng-pdf-23..> | 2021-02-24 07:00 | 12K | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:48 | 12K | ||
LOA_NCHADS_CRS-pdf-2..> | 2021-02-16 15:10 | 12K | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 12K | ||
OI-q3-2006-pdf-212x3..> | 2021-02-28 08:34 | 12K | ||
HSS_2010-Report-pdf-..> | 2021-02-15 15:52 | 12K | ||
Guidance-to-the-Oper..> | 2021-02-19 17:11 | 12K | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 12K | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 12K | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 12K | ||
MHS-KH-pdf-212x300.jpg | 2021-02-16 14:45 | 12K | ||
National-Guide-on-ST..> | 2021-02-21 16:40 | 12K | ||
SOP-CoPCT-KH-pdf-212..> | 2021-02-17 08:31 | 12K | ||
Book-CoPCT-Kh-pdf-21..> | 2021-02-22 15:33 | 12K | ||
EWI-2008-2010-pdf-30..> | 2021-02-28 15:59 | 12K | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 12K | ||
FHI-KH-pdf-212x300.jpg | 2021-02-16 15:17 | 12K | ||
Concept-paper-for-sy..> | 2021-02-23 15:25 | 12K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 12K | ||
Letter-of-Agreement-..> | 2021-02-16 09:13 | 12K | ||
National-Consolidate..> | 2021-02-19 17:37 | 11K | ||
SOP-CQI-EN-pdf-212x3..> | 2021-02-17 08:01 | 11K | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 11K | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 11K | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 11K | ||
core-indicator-en-pd..> | 2021-02-21 16:12 | 11K | ||
SOP-for-Social-Care-..> | 2021-02-24 07:33 | 11K | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 11K | ||
D4T-Phasing-Out-EN-p..> | 2021-02-17 07:32 | 11K | ||
core-indicator-kh-pd..> | 2021-02-21 16:13 | 11K | ||
Standard-Protocol-Ba..> | 2021-02-17 03:54 | 11K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 11K | ||
ARV-Guideline-2005-E..> | 2021-02-21 16:28 | 11K | ||
LOA_NCHADS_worldvisi..> | 2021-02-16 15:04 | 11K | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 11K | ||
BIACM-Anual-Report-2..> | 2021-02-24 04:41 | 11K | ||
Agreement_NCHADSNBTC..> | 2021-02-16 09:26 | 11K | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 11K | ||
ARV-guideline-2007-E..> | 2021-02-21 16:23 | 11K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 11K | ||
SOP-CoPCT-EN-pdf-212..> | 2021-02-17 08:44 | 11K | ||
Book-CoPCT-English-p..> | 2021-02-22 15:30 | 11K | ||
SOP-for-HBC-ENG-pdf-..> | 2021-02-24 06:54 | 11K | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 10K | ||
SOP-for-NCHADS-PBSI-..> | 2021-02-23 15:42 | 10K | ||
Agreement-Nchads-Mag..> | 2021-02-15 15:36 | 10K | ||
SOP-Kh-pdf-212x300.jpg | 2021-02-24 06:39 | 10K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 10K | ||
SOP-logistic-KH-pdf-..> | 2021-02-24 07:05 | 10K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 10K | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:13 | 10K | ||
SOP-En-pdf-212x300.jpg | 2021-02-24 06:39 | 10K | ||
linkresponse-q4-2009..> | 2021-02-27 09:00 | 10K | ||
SOP-for-PBSI-EN-pdf-..> | 2021-02-24 06:41 | 10K | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 10K | ||
OI-q2-2006-pdf-150x1..> | 2021-02-28 08:31 | 9.9K | ||
National-Guideline-f..> | 2021-02-21 16:19 | 9.7K | ||
Agreement-NCHADS-AHF..> | 2021-02-16 14:28 | 9.6K | ||
ARV-guideline-2005-K..> | 2021-02-21 16:28 | 9.6K | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 9.5K | ||
ART-q2-2006-pdf-150x..> | 2021-02-28 08:31 | 9.5K | ||
SOP-for-PBSI-KH-pdf-..> | 2021-02-24 06:41 | 9.4K | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 9.4K | ||
HBC-q4-2006-pdf-150x..> | 2021-02-28 08:37 | 9.2K | ||
slides-sti-en-pdf-15..> | 2021-02-16 15:46 | 9.2K | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 9.2K | ||
oi-q1-2009-pdf-150x1..> | 2021-02-27 08:37 | 9.2K | ||
art-q1-2009-pdf-150x..> | 2021-02-27 08:36 | 9.2K | ||
SOP-logistic-EN-pdf-..> | 2021-02-24 07:05 | 9.1K | ||
hbc-q4-2008-pdf-150x..> | 2021-02-28 08:05 | 9.1K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 9.1K | ||
STI-q4-2006-pdf-116x..> | 2021-02-28 08:37 | 9.1K | ||
VCCT-q2-2006-pdf-150..> | 2021-02-28 08:32 | 9.1K | ||
Poligy-and-Guideline..> | 2021-02-21 16:30 | 9.0K | ||
VCCT-q1-2006-pdf-150..> | 2021-02-28 08:23 | 9.0K | ||
KHANA-KH-pdf-232x300..> | 2021-02-16 15:13 | 9.0K | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 9.0K | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 8.9K | ||
hbc-q4-2009-pdf-150x..> | 2021-02-27 09:00 | 8.9K | ||
SOP-CDC-KH-pdf-212x3..> | 2021-02-24 07:22 | 8.9K | ||
linkresponse-q2-2009..> | 2021-02-27 08:41 | 8.9K | ||
VCCT-q2-2007-pdf-150..> | 2021-02-28 08:10 | 8.9K | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 8.8K | ||
hbc-q2-2009-pdf-150x..> | 2021-02-27 08:41 | 8.8K | ||
hbc-q1-2009-pdf-150x..> | 2021-02-27 08:36 | 8.7K | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:12 | 8.7K | ||
report-ewi-2011-pdf-..> | 2021-02-28 15:54 | 8.7K | ||
HBC-q4-2007-pdf-150x..> | 2021-02-28 08:18 | 8.6K | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 8.6K | ||
VCCT_User_Manual-pdf..> | 2021-02-20 16:48 | 8.6K | ||
National-Guidelines-..> | 2021-02-20 16:59 | 8.6K | ||
sti-q4-2009-pdf-106x..> | 2021-02-27 09:00 | 8.5K | ||
sti-q4-2008-pdf-106x..> | 2021-02-28 08:05 | 8.5K | ||
Adult_HIV_Management..> | 2021-02-16 06:39 | 8.5K | ||
VCCT-q3-2007-pdf-150..> | 2021-02-28 08:13 | 8.5K | ||
sop-coc-08-kh-pdf-21..> | 2021-02-23 15:35 | 8.5K | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 8.4K | ||
Guidance-to-enhance-..> | 2021-02-19 17:20 | 8.4K | ||
CQI_dashboard_usergu..> | 2021-02-20 16:54 | 8.4K | ||
Report-B-CoPCT-Annua..> | 2021-02-24 03:31 | 8.4K | ||
Strategic-Plan-2004-..> | 2021-02-21 16:06 | 8.4K | ||
Adult_HIV_Management..> | 2021-02-16 06:38 | 8.3K | ||
Strategic-Plan-2001-..> | 2021-02-21 16:09 | 8.3K | ||
VCCT-q4-2007-pdf-109..> | 2021-02-28 08:18 | 8.3K | ||
SOP-mmm-EN-pdf-116x1..> | 2021-02-23 15:33 | 8.3K | ||
OI_ART_User_Manual-p..> | 2021-02-20 16:44 | 8.2K | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 8.2K | ||
LOA-NCHADS-and-CPN-p..> | 2021-02-21 16:21 | 8.2K | ||
Linked-Response-of-P..> | 2021-02-21 16:45 | 8.2K | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 8.1K | ||
vcct-q4-2008-pdf-109..> | 2021-02-28 08:05 | 8.1K | ||
ARV-guideline-2007-K..> | 2021-02-21 16:24 | 8.1K | ||
vcct-q2-2009-pdf-106..> | 2021-02-27 08:41 | 8.0K | ||
vcct-q3-2008-pdf-109..> | 2021-02-28 08:02 | 8.0K | ||
ART-q1-2006-pdf-150x..> | 2021-02-28 08:23 | 7.9K | ||
OI-q1-2006-pdf-150x1..> | 2021-02-28 08:23 | 7.9K | ||
Guidline-screening-o..> | 2021-02-16 06:50 | 7.9K | ||
sop-coc-08-en-pdf-21..> | 2021-02-23 15:35 | 7.9K | ||
HBC-q1-2007-pdf-104x..> | 2021-02-28 08:08 | 7.9K | ||
Rapid-assessment-kh-..> | 2021-02-28 16:02 | 7.9K | ||
positive-prevention-..> | 2021-02-21 09:18 | 7.9K | ||
vcct-q1-2008-pdf-106..> | 2021-02-28 07:43 | 7.8K | ||
KHANA-EN-pdf-116x150..> | 2021-02-16 15:13 | 7.8K | ||
SOP-for-MMM-ENG-pdf-..> | 2021-02-24 06:48 | 7.8K | ||
STD_User_Manual-pdf-..> | 2021-02-20 16:51 | 7.8K | ||
HBC-q2-2007-pdf-150x..> | 2021-02-28 08:10 | 7.8K | ||
hbc-q2-2008-pdf-150x..> | 2021-02-28 07:48 | 7.8K | ||
hbc-q1-2008-pdf-150x..> | 2021-02-28 07:43 | 7.8K | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 7.8K | ||
DBS-HSS-KH-pdf-106x1..> | 2021-02-23 15:46 | 7.7K | ||
OI-Guideline-Booklet..> | 2021-02-21 16:33 | 7.7K | ||
VCCT-q4-2006-pdf-109..> | 2021-02-28 08:37 | 7.7K | ||
oi-q3-2009-pdf-106x1..> | 2021-02-27 08:45 | 7.7K | ||
Integrate-OVC-into-C..> | 2021-02-24 07:30 | 7.7K | ||
HBC-q3-2007-pdf-150x..> | 2021-02-28 08:12 | 7.6K | ||
SOP-for-MMM-KHM-pdf-..> | 2021-02-24 06:48 | 7.6K | ||
art-q3-2009-pdf-106x..> | 2021-02-27 08:44 | 7.6K | ||
SOP-for-HBC-KHM-pdf-..> | 2021-02-24 06:54 | 7.6K | ||
oi-q4-2009-pdf-106x1..> | 2021-02-27 09:00 | 7.6K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 7.6K | ||
STI-q2-2007-pdf-109x..> | 2021-02-28 08:10 | 7.6K | ||
National_Guideline_S..> | 2021-02-15 09:26 | 7.5K | ||
SOP-mmm-KH-pdf-116x1..> | 2021-02-23 15:33 | 7.5K | ||
SOP-KH-pdf-1-116x150..> | 2021-02-24 07:02 | 7.4K | ||
SOP-CQI-KH-pdf-106x1..> | 2021-02-17 07:56 | 7.4K | ||
DBS-HSS-EN-pdf-106x1..> | 2021-02-23 15:46 | 7.4K | ||
oi-q2-2009-pdf-109x1..> | 2021-02-27 08:41 | 7.4K | ||
art-q4-2009-pdf-106x..> | 2021-02-27 09:00 | 7.4K | ||
oi-q1-2008-pdf-109x1..> | 2021-02-28 07:43 | 7.4K | ||
art-q2-2009-pdf-109x..> | 2021-02-27 08:41 | 7.4K | ||
OI-prophylaxis-Guide..> | 2021-02-21 16:34 | 7.4K | ||
MHS-EN-pdf-106x150.jpg | 2021-02-16 14:45 | 7.4K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 7.4K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 7.4K | ||
FHI-EN-pdf-116x150.jpg | 2021-02-16 15:17 | 7.3K | ||
positive-prevention-..> | 2021-02-21 09:18 | 7.3K | ||
HBC-q2-2006-pdf-150x..> | 2021-02-28 08:31 | 7.3K | ||
Concept-Paper-in-Khm..> | 2021-02-23 15:21 | 7.3K | ||
ART-q4-2006-pdf-109x..> | 2021-02-28 08:37 | 7.3K | ||
oi-q3-2008-pdf-109x1..> | 2021-02-28 08:01 | 7.3K | ||
art-q4-2008-pdf-110x..> | 2021-02-28 08:05 | 7.3K | ||
art-q1-2008-pdf-109x..> | 2021-02-28 07:43 | 7.3K | ||
National-Consolidate..> | 2021-02-19 17:37 | 7.3K | ||
oi-q3-2007-pdf-106x1..> | 2021-02-28 08:12 | 7.3K | ||
art-q2-2008-pdf-108x..> | 2021-02-28 07:48 | 7.3K | ||
TasP_NCHADS-Concept-..> | 2021-02-23 15:03 | 7.2K | ||
oi-q4-2008-pdf-110x1..> | 2021-02-28 08:05 | 7.2K | ||
art-q3-2007-pdf-106x..> | 2021-02-28 08:12 | 7.2K | ||
SOP-ORCUP-KH-pdf-106..> | 2021-02-24 07:00 | 7.2K | ||
art-q3-2008-pdf-109x..> | 2021-02-28 08:01 | 7.2K | ||
Policy-and-strategy-..> | 2021-02-21 16:15 | 7.2K | ||
oi-q2-2008-pdf-108x1..> | 2021-02-28 07:48 | 7.2K | ||
OI-q4-2006-pdf-109x1..> | 2021-02-28 08:37 | 7.2K | ||
MHS-KH-pdf-106x150.jpg | 2021-02-16 14:45 | 7.1K | ||
VCCT-q1-2007-pdf-104..> | 2021-02-28 08:08 | 7.1K | ||
Amendement-to-sop-HB..> | 2021-02-24 07:25 | 7.1K | ||
guide2-pdf-106x150.jpg | 2021-02-21 09:36 | 7.1K | ||
vcct-q4-2009-pdf-150..> | 2021-02-27 09:00 | 7.1K | ||
STI-q4-2007-pdf-116x..> | 2021-02-28 08:18 | 7.1K | ||
tb-q3-2009-pdf-116x1..> | 2021-02-27 08:45 | 7.1K | ||
vcct-q2-2008-pdf-150..> | 2021-02-28 07:48 | 7.1K | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 7.1K | ||
SOP-ANC-syphilis-scr..> | 2021-02-23 15:37 | 7.0K | ||
National-Guidelines-..> | 2021-02-19 17:30 | 7.0K | ||
STI-Sentinel-Survey-..> | 2021-02-28 09:17 | 7.0K | ||
National-Guidelines-..> | 2021-02-21 16:43 | 6.9K | ||
HBC-q3-2006-pdf-106x..> | 2021-02-28 08:34 | 6.9K | ||
approval-letter-for-..> | 2021-02-21 09:16 | 6.9K | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:49 | 6.9K | ||
tb-q4-2009-pdf-106x1..> | 2021-02-27 09:00 | 6.9K | ||
SOP-EN-pdf-1-116x150..> | 2021-02-24 07:02 | 6.9K | ||
RACHA-EN-pdf-106x150..> | 2021-02-16 15:22 | 6.8K | ||
National-Guidelines-..> | 2021-02-19 17:30 | 6.8K | ||
RACHA-KH-pdf-106x150..> | 2021-02-16 15:22 | 6.8K | ||
National-Guidelines-..> | 2021-02-20 16:59 | 6.8K | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 6.8K | ||
Conceptual-Framework..> | 2021-02-23 15:07 | 6.8K | ||
Concept-Paper-in-Eng..> | 2021-02-23 15:21 | 6.8K | ||
core-indicator-en-pd..> | 2021-02-21 16:12 | 6.8K | ||
SOP-for-Social-Care-..> | 2021-02-24 07:33 | 6.8K | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 6.8K | ||
SOP-ORCUP-Eng-pdf-11..> | 2021-02-24 07:00 | 6.7K | ||
LOA_NCHADS_CRS-pdf-1..> | 2021-02-16 15:10 | 6.7K | ||
art-q4-2007-pdf-109x..> | 2021-02-28 08:18 | 6.7K | ||
SOP-Expanding-the-CO..> | 2021-02-24 06:50 | 6.7K | ||
LOA_-NCHADS_KHANA_20..> | 2021-02-16 14:39 | 6.7K | ||
oi-q4-2007-pdf-109x1..> | 2021-02-28 08:18 | 6.7K | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 6.7K | ||
National-Guide-for-S..> | 2021-02-21 16:48 | 6.7K | ||
Cambodia-eMTCT-Road-..> | 2021-02-16 06:54 | 6.7K | ||
Female-worker-KH-pdf..> | 2021-02-23 15:28 | 6.6K | ||
D4T-Phasing-Out-KH-p..> | 2021-02-17 07:28 | 6.6K | ||
SOP-for-NCHADS-PBSI-..> | 2021-02-23 15:42 | 6.6K | ||
STI-q3-2007-pdf-108x..> | 2021-02-28 08:13 | 6.6K | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 6.6K | ||
boosted-LR-SOP_updat..> | 2021-02-22 15:48 | 6.6K | ||
National-Guide-for-S..> | 2021-02-21 16:37 | 6.6K | ||
hbc-q3-2009-pdf-150x..> | 2021-02-27 08:44 | 6.5K | ||
Guidline-screening-o..> | 2021-02-16 06:49 | 6.5K | ||
FHI-KH-pdf-106x150.jpg | 2021-02-16 15:17 | 6.5K | ||
sti-q1-2009-pdf-106x..> | 2021-02-27 08:37 | 6.5K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 6.5K | ||
National-Guide-on-ST..> | 2021-02-21 16:40 | 6.5K | ||
SOP-for-HBC-ENG-pdf-..> | 2021-02-24 06:54 | 6.5K | ||
guide3-pdf-106x150.jpg | 2021-02-21 09:33 | 6.5K | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 6.5K | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 6.5K | ||
psf_ci-pdf-106x150.jpg | 2021-02-16 14:59 | 6.5K | ||
New-Biological-Crite..> | 2021-02-20 16:35 | 6.5K | ||
National-Consolidate..> | 2021-02-19 17:37 | 6.5K | ||
ARV-Guideline-2005-E..> | 2021-02-21 16:28 | 6.4K | ||
guidelines-sti_rti-c..> | 2021-02-21 15:59 | 6.4K | ||
sti-q2-2009-pdf-106x..> | 2021-02-27 08:41 | 6.4K | ||
EWI-2008-2010-pdf-15..> | 2021-02-28 15:59 | 6.4K | ||
SOP-CQI-EN-pdf-106x1..> | 2021-02-17 08:01 | 6.4K | ||
SOP-logistic-KH-pdf-..> | 2021-02-24 07:05 | 6.4K | ||
SOP-CoPCT-KH-pdf-106..> | 2021-02-17 08:31 | 6.4K | ||
Book-CoPCT-Kh-pdf-10..> | 2021-02-22 15:33 | 6.4K | ||
guideline-CD4350-pdf..> | 2021-02-21 15:56 | 6.4K | ||
STI-Policy-and-Strat..> | 2021-02-21 16:26 | 6.4K | ||
slides-sti-kh-pdf-15..> | 2021-02-16 15:39 | 6.3K | ||
SOPs-for-STI-clinic-..> | 2021-02-24 07:13 | 6.3K | ||
vcct-q3-2009-pdf-150..> | 2021-02-27 08:45 | 6.3K | ||
HSS_2010-Report-pdf-..> | 2021-02-15 15:52 | 6.2K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 6.2K | ||
ARV-guideline-2007-E..> | 2021-02-21 16:23 | 6.2K | ||
SOP-NCHADS-US-CDC-20..> | 2021-02-23 15:40 | 6.2K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 6.1K | ||
sti-q3-2009-pdf-106x..> | 2021-02-27 08:45 | 6.1K | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 6.1K | ||
Poligy-and-Guideline..> | 2021-02-21 16:30 | 6.1K | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 6.0K | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 6.0K | ||
NG_on_Management_of_..> | 2021-02-20 16:28 | 6.0K | ||
Agreement_NCHADSNBTC..> | 2021-02-16 09:26 | 6.0K | ||
D4T-Phasing-Out-EN-p..> | 2021-02-17 07:32 | 6.0K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 6.0K | ||
vcct-q1-2009-pdf-107..> | 2021-02-27 08:37 | 6.0K | ||
BIACM-Anual-Report-2..> | 2021-02-24 04:41 | 6.0K | ||
SOP-CoPCT-EN-pdf-106..> | 2021-02-17 08:44 | 5.9K | ||
Book-CoPCT-English-p..> | 2021-02-22 15:30 | 5.9K | ||
SOP-logistic-EN-pdf-..> | 2021-02-24 07:05 | 5.9K | ||
SOP-En-pdf-106x150.jpg | 2021-02-24 06:39 | 5.9K | ||
SOP-Kh-pdf-106x150.jpg | 2021-02-24 06:39 | 5.9K | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 5.9K | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 5.9K | ||
BSS-2010_Disseminati..> | 2021-02-28 16:00 | 5.9K | ||
Agreement-Nchads-Mag..> | 2021-02-15 15:36 | 5.9K | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 5.9K | ||
SOP-to-Initiate-a-li..> | 2021-02-23 15:44 | 5.9K | ||
LOA_NCHADS_worldvisi..> | 2021-02-16 15:04 | 5.8K | ||
OI-Guideline-for-HIV..> | 2021-02-20 16:56 | 5.8K | ||
National-Guidelines-..> | 2021-02-20 16:59 | 5.8K | ||
ARV-guideline-2005-K..> | 2021-02-21 16:28 | 5.8K | ||
Agreement-NCHADS-AHF..> | 2021-02-16 14:28 | 5.7K | ||
Lost-to-Follow-up-Le..> | 2021-02-19 17:40 | 5.7K | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 5.7K | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 5.7K | ||
Guidance-to-enhance-..> | 2021-02-19 17:18 | 5.7K | ||
National-Guideline-f..> | 2021-02-21 16:19 | 5.7K | ||
strategic-plan-08-10..> | 2021-02-21 16:03 | 5.7K | ||
SP-for-hiv_aids-and-..> | 2021-02-19 17:34 | 5.7K | ||
Letter-of-Agreement-..> | 2021-02-16 09:13 | 5.7K | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:13 | 5.6K | ||
KHANA-KH-pdf-116x150..> | 2021-02-16 15:13 | 5.6K | ||
Children_ICA_ART-man..> | 2021-02-16 06:31 | 5.6K | ||
NGTreatment_art_chil..> | 2021-02-21 09:13 | 5.6K | ||
Strategic-Plan-2001-..> | 2021-02-21 16:09 | 5.5K | ||
Standard-Protocol-Ba..> | 2021-02-17 03:47 | 5.5K | ||
Guidance-to-the-Oper..> | 2021-02-19 17:12 | 5.5K | ||
HIV-Magt-guidelines_..> | 2021-02-20 16:32 | 5.4K | ||
linkresponse-q3-2009..> | 2021-02-27 08:45 | 5.4K | ||
Dissemination-of-HIV..> | 2021-02-28 15:56 | 5.4K | ||
NGTreatment_oi_child..> | 2021-02-21 09:07 | 5.4K | ||
sti-q1-2008-pdf-106x..> | 2021-02-28 07:43 | 5.3K | ||
SOP-for-Prison-Setti..> | 2021-02-22 15:53 | 5.3K | ||
SOP-for-Prison-Setti..> | 2021-02-23 15:17 | 5.3K | ||
OI-Guideline-Booklet..> | 2021-02-21 16:33 | 5.3K | ||
report-ewi-2011-pdf-..> | 2021-02-28 15:54 | 5.3K | ||
ACM_Book-2013-pdf-10..> | 2021-02-20 16:40 | 5.2K | ||
Female-worker-EN-pdf..> | 2021-02-23 15:28 | 5.2K | ||
linkresponse-q1-2009..> | 2021-02-27 08:36 | 5.2K | ||
sti-q3-2008-pdf-109x..> | 2021-02-28 08:02 | 5.2K | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 5.2K | ||
SOP-TB-and-HIV-ENG-p..> | 2021-02-24 06:46 | 4.9K | ||
VCCT-q3-2006-pdf-106..> | 2021-02-28 08:34 | 4.9K | ||
NG_4ed_on_Diagnosis-..> | 2021-02-20 16:15 | 4.9K | ||
Adult_HIV_Management..> | 2021-02-16 06:38 | 4.9K | ||
Adult_HIV_Management..> | 2021-02-16 06:39 | 4.8K | ||
SOP-for-PBSI-EN-pdf-..> | 2021-02-24 06:41 | 4.8K | ||
core-indicator-kh-pd..> | 2021-02-21 16:13 | 4.8K | ||
Guidline-screening-o..> | 2021-02-16 06:50 | 4.6K | ||
SOP-for-PBSI-KH-pdf-..> | 2021-02-24 06:41 | 4.6K | ||
ART-q3-2006-pdf-106x..> | 2021-02-28 08:34 | 4.6K | ||
sti-q2-2008-pdf-108x..> | 2021-02-28 07:48 | 4.6K | ||
Guidance-to-the-Oper..> | 2021-02-19 17:11 | 4.5K | ||
Concept-paper-for-sy..> | 2021-02-23 15:25 | 4.5K | ||
OI-q3-2006-pdf-106x1..> | 2021-02-28 08:34 | 4.5K | ||
Guidline-screening-o..> | 2021-02-16 06:49 | 4.5K | ||
SOP-for-Clinicial-Me..> | 2021-02-23 15:12 | 4.5K | ||
SOP-CDC-KH-pdf-106x1..> | 2021-02-24 07:22 | 4.2K | ||
the-3i-in-coc-settin..> | 2021-02-23 15:23 | 4.2K | ||
sop-coc-08-kh-pdf-10..> | 2021-02-23 15:35 | 4.1K | ||
sop-coc-08-en-pdf-10..> | 2021-02-23 15:35 | 4.1K | ||
Standard-Protocol-Ba..> | 2021-02-17 03:54 | 3.7K | ||